NCT01102400 - A Study of MEDI-575 in Patients With Advanced Solid Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Advanced Solid Malignancies

Interventions

DRUG

MEDI-575

MEDI-575 will be administered weekly or every 3 weeks as IV infusion as part of a 21-day treatment cycle. One or two doses will be selected for expansion part

Trial Locations (5)

Unknown

Research Site, Nagoya

Research Site, Kashiwa

Research Site, Matsuyama

Research Site, Chuo-ku

Research Site, Sunto-gun